Cover Image
市場調查報告書

披衣菌感染:全球臨床實驗檢討

Chlamydia Infections Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 177202
出版日期 內容資訊 英文 67 Pages
訂單完成後即時交付
價格
Back to Top
披衣菌感染:全球臨床實驗檢討 Chlamydia Infections Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月28日 內容資訊: 英文 67 Pages
簡介

披衣菌感染是由非常細小的Chlamydia trachomatis(砂眼披衣菌)引起的性感染病(STI)。會影響頸椎、尿道、輸卵管、子宮、鼻咽、副睪丸等部位。

本報告提供披衣菌感染的治療藥相關之臨床實驗調查分析,提供您臨床實驗數及受驗人數,各階段及Phase狀況,有潛力企業,正在開發的治療藥的資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:感染性疾病臨床實驗上披衣菌感染所佔的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:感染性疾病臨床實驗上披衣菌感染所佔的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商類別臨床實驗

有潛力的贊助商

  • 披衣菌感染的治療藥臨床實驗的主要參與企業

有潛力藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • kyorin製藥集團
    • Endo International plc
    • Cempra Pharmaceuticals, Inc.
    • ActivBiotics Pharma, LLC
    • Actavis plc
  • 主要大學·研究機關·醫院臨床實驗概要
    • University of California, San Francisco
    • Johns Hopkins University
    • Centers for Disease Control and Prevention
    • National Heart, Lung, and Blood Institute
    • University of Pittsburgh
    • The University of Melbourne
    • Washington University School of Medicine
    • London School of Hygiene & Tropical Medicine
    • Population Council
    • Barts and The London NHS Trust

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2431CTIDB

GlobalData's clinical trial report, "Chlamydia Infections Global Clinical Trials Review, H2, 2014" provides data on the Chlamydia Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chlamydia Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chlamydia Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Chlamydia Infections
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
    • Top Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Chlamydia Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Chlamydia Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Chlamydia Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Chlamydia Infections Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Kyorin Holdings, Inc.
      • Clinical Trial Overview of Kyorin Holdings, Inc.
      • Endo International plc
      • Clinical Trial Overview of Endo International plc
      • Cempra Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cempra Pharmaceuticals, Inc.
      • ActivBiotics Pharma, LLC
      • Clinical Trial Overview of ActivBiotics Pharma, LLC
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
    • Clinical Trial Overview of Top Institutes / Government
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Johns Hopkins University
      • Clinical Trial Overview of Johns Hopkins University
      • Centers for Disease Control and Prevention
      • Clinical Trial Overview of Centers for Disease Control and Prevention
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • The University of Melbourne
      • Clinical Trial Overview of The University of Melbourne
      • Washington University School of Medicine
      • Clinical Trial Overview of Washington University School of Medicine
      • London School of Hygiene & Tropical Medicine
      • Clinical Trial Overview of London School of Hygiene & Tropical Medicine
      • Population Council
      • Clinical Trial Overview of Population Council
      • Barts and The London NHS Trust
      • Clinical Trial Overview of Barts and The London NHS Trust
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Chlamydia Infections Therapeutics, Global, Clinical Trials by Region, 2014*
  • Chlamydia Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Chlamydia Infections Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Chlamydia Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chlamydia Infections Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Chlamydia Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Chlamydia Infections Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chlamydia Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyorin Holdings, Inc., 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo International plc, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra Pharmaceuticals, Inc., 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by ActivBiotics Pharma, LLC, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Melbourne, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene & Tropical Medicine, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Population Council, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Barts and The London NHS Trust, 2014*

List of Figures

  • Chlamydia Infections Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Chlamydia Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chlamydia Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Chlamydia Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Chlamydia Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Chlamydia Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Chlamydia Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chlamydia Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chlamydia Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top